P1261: ALLG LABORATORY SCIENCE STUDY LS21: MOLECULAR CORRELATES OF RESPONSE IN RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (RRMZL) PATIENTS TREATED WITH ZANUBRUTINIB IN THE MAGNOLIA TRIAL

• M. Tatarczuch,
• M. Waltham,
• J. Shortt,
• E. Hawkes,
• S.-J. Ho,
• J. Trotman,
• D. Brasacchio,
• M. Co,
• J. Li,
• V. Ramakrishnan,
• K. Dunne,
• S. Opat,
• G. Gregory

Affiliations

M. Tatarczuch

1 Clinical Sciences at Monash Health, Monash University

M. Waltham

1 Clinical Sciences at Monash Health, Monash University

J. Shortt

1 Clinical Sciences at Monash Health, Monash University

E. Hawkes

3 Eastern Health

S.-J. Ho

6 Haematology, St George Hospital

J. Trotman

8 Haematology, Concord Repatriation General Hospital

D. Brasacchio

1 Clinical Sciences at Monash Health, Monash University

M. Co

10 BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States of America

J. Li

10 BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States of America

V. Ramakrishnan

10 BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, United States of America

K. Dunne

11 Australasian Leukaemia & Lymphoma Group, Melbourne, Australia

S. Opat

1 Clinical Sciences at Monash Health, Monash University

G. Gregory

1 Clinical Sciences at Monash Health, Monash University